| Item Type | Name |
|
Concept
|
Antibodies, Neoplasm
|
|
Concept
|
Myeloproliferative Disorders
|
|
Concept
|
Biomarkers, Tumor
|
|
Concept
|
Tumor Necrosis Factor-alpha
|
|
Concept
|
Tumor Stem Cell Assay
|
|
Concept
|
Tumor Cells, Cultured
|
|
Concept
|
Neoplasms, Second Primary
|
|
Concept
|
Bone Marrow Neoplasms
|
|
Concept
|
Hematologic Neoplasms
|
|
Concept
|
Tumor Suppressor Proteins
|
|
Concept
|
Cell Line, Tumor
|
|
Concept
|
Neoplasm Proteins
|
|
Concept
|
Neoplasms
|
|
Academic Article
|
Protein kinase B (c-Akt), phosphatidylinositol 3-kinase, and STAT5 are activated by erythropoietin (EPO) in HCD57 erythroid cells but are constitutively active in an EPO-independent, apoptosis-resistant subclone (HCD57-SREI cells).
|
|
Academic Article
|
Regulation of myeloma cell growth through Akt/Gsk3/forkhead signaling pathway.
|
|
Academic Article
|
Fludarabine and melphalan-based conditioning for patients with advanced hematological malignancies relapsing after a previous hematopoietic stem cell transplant.
|
|
Academic Article
|
Cutting edge: activation of the p38 mitogen-activated protein kinase signaling pathway mediates cytokine-induced hemopoietic suppression in aplastic anemia.
|
|
Academic Article
|
Tumor necrosis factor-alpha expressed constitutively in erythroid cells or induced by erythropoietin has negative and stimulatory roles in normal erythropoiesis and erythroleukemia.
|
|
Academic Article
|
Role of JunB in erythroid differentiation.
|
|
Academic Article
|
Safety and outcome after fludarabine-thiotepa-TBI conditioning for allogeneic transplantation: a prospective study of 30 patients with hematologic malignancies.
|
|
Academic Article
|
Regimen-related toxicity after fludarabine-melphalan conditioning: a prospective study of 31 patients with hematologic malignancies.
|
|
Academic Article
|
Differentiation stage-specific activation of p38 mitogen-activated protein kinase isoforms in primary human erythroid cells.
|
|
Academic Article
|
Growth control of multiple myeloma cells through inhibition of glycogen synthase kinase-3.
|
|
Academic Article
|
Coupled transcription-splicing regulation of mutually exclusive splicing events at the 5' exons of protein 4.1R gene.
|
|
Academic Article
|
High levels of tRNA abundance and alteration of tRNA charging by bortezomib in multiple myeloma.
|
|
Academic Article
|
Activation of protein kinase C{eta} by type I interferons.
|
|
Academic Article
|
Patterns and kinetics of T-cell chimerism after allo transplant with alemtuzumab-based conditioning: mixed chimerism protects from GVHD, but does not portend disease recurrence.
|
|
Academic Article
|
Reduced SMAD7 leads to overactivation of TGF-beta signaling in MDS that can be reversed by a specific inhibitor of TGF-beta receptor I kinase.
|
|
Academic Article
|
Pretreatment C-reactive protein is a predictor for outcomes after reduced-intensity allogeneic hematopoietic cell transplantation.
|
|
Academic Article
|
Identification of a novel microRNA cluster miR-193b-365 in multiple myeloma.
|
|
Academic Article
|
Erythroid-specific processing of human beta spectrin I pre-mRNA.
|
|
Academic Article
|
CrkL and CrkII participate in the generation of the growth inhibitory effects of interferons on primary hematopoietic progenitors.
|
|
Academic Article
|
Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome.
|
|
Academic Article
|
Differential requirements for survivin in hematopoietic cell development.
|
|
Academic Article
|
Immune reconstitution after combined haploidentical and umbilical cord blood transplant.
|
|
Academic Article
|
Essential role for the Mnk pathway in the inhibitory effects of type I interferons on myeloproliferative neoplasm (MPN) precursors.
|
|
Academic Article
|
IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells.
|
|
Academic Article
|
Clofarabine-associated acute kidney injury in patients undergoing hematopoietic stem cell transplant.
|
|
Academic Article
|
Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival.
|
|
Academic Article
|
The prognostic value of serum C-reactive protein, ferritin, and albumin prior to allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndromes.
|
|
Academic Article
|
Identifying Inherited and Acquired Genetic Factors Involved in Poor Stem Cell Mobilization and Donor-Derived Malignancy.
|
|
Academic Article
|
Epigenetically Aberrant Stroma in MDS Propagates Disease via Wnt/ß-Catenin Activation.
|
|
Academic Article
|
Expression of functional folate receptors in multiple myeloma.
|
|
Academic Article
|
Antisense STAT3 inhibitor decreases viability of myelodysplastic and leukemic stem cells.
|
|
Academic Article
|
Disruption of erythroid nuclear opening and histone release in myelodysplastic syndromes.
|
|
Academic Article
|
Cytokine-Regulated Phosphorylation and Activation of TET2 by JAK2 in Hematopoiesis.
|
|
Academic Article
|
Loss of Function of DOCK4 in Myelodysplastic Syndromes Stem Cells is Restored by Inhibitors of DOCK4 Signaling Networks.
|
|
Academic Article
|
Stem cell mutations can be detected in myeloma patients years before onset of secondary leukemias.
|
|
Academic Article
|
PU.1-Dependent Enhancer Inhibition Separates Tet2-Deficient Hematopoiesis from Malignant Transformation.
|